How miRNAs can protect humans from coronaviruses COVID-19, SARS-CoV, and MERS-CoV

A. Ivashchenko, A. Rakhmetullina, D. Aisina
{"title":"How miRNAs can protect humans from coronaviruses COVID-19, SARS-CoV, and MERS-CoV","authors":"A. Ivashchenko, A. Rakhmetullina, D. Aisina","doi":"10.21203/rs.3.rs-16264/v1","DOIUrl":null,"url":null,"abstract":"\n Viral diseases cause significant harm to human health and often cause high mortality. In the past twenty years, humanity has undergone infection by SARS-CoV (severe acute respiratory syndrome), MERS-CoV (Middle East respiratory syndrome) and COVID-19 coronaviruses, which spread from animals to humans and from person to person. These diseases have led to large economic losses. To fight coronaviruses and other viruses, it is proposed to use miRNAs, which regulate protein synthesis at the translational level. MirTarget program was used to determine the following binding characteristics: the locations of miRNA binding sites in the 3'UTR, 5'UTR, and CDS; the free energy interaction ∆G between miRNA and mRNA; the ΔG/ΔGm value, where ΔGm is equal to the free energy binding of miRNA with its full complementary nucleotide sequence; and the nucleotide interaction schemes between miRNAs and mRNAs. Out of 2565 miRNAs, miR-4778-3p, miR-6864-5p and miR-5197-3p were identified as the most effectively interacting with the gRNA of SARS-CoV, MERS-CoV and COVID-19, respectively. Based on the miR-4778-3p, miR-6864-5p and miR-5197-3p sequences, complete complementary miRNA (cc-miR) binding sites in the gRNA coronaviruses were created. The detected binding sites of these cc-miRs did not form intramolecular complexes in the 2D structure of the gRNA of SARS-CoV, MERS-CoV, and COVID-19 with a value of more than 85%. Therefore, the cc-miRs will bind gRNA at these sites without competition. The cc-miRs for SARS-CoV, MERS-CoV, and COVID-19 did not have target genes among the 17508 human coding genes with a ΔG/ΔGm of more than 85%, which implies the absence of side effects of these cc-miRs on the translation of human mRNAs. cc-miRs can be used as therapeutic agents by incorporating them into exosomes or other vesicles and introducing them into the blood or lung by inhalation. The introduction of cc-miR into the blood will suppress the reproduction of the virus in the blood and in all organs into which it can enter. The proposed method of inhibiting the reproduction of coronaviruses can be used for other viruses.","PeriodicalId":199580,"journal":{"name":"Bioinformatics of Genome Regulation and Structure/ Systems Biology","volume":"23 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2020-03-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"34","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioinformatics of Genome Regulation and Structure/ Systems Biology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21203/rs.3.rs-16264/v1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 34

Abstract

Viral diseases cause significant harm to human health and often cause high mortality. In the past twenty years, humanity has undergone infection by SARS-CoV (severe acute respiratory syndrome), MERS-CoV (Middle East respiratory syndrome) and COVID-19 coronaviruses, which spread from animals to humans and from person to person. These diseases have led to large economic losses. To fight coronaviruses and other viruses, it is proposed to use miRNAs, which regulate protein synthesis at the translational level. MirTarget program was used to determine the following binding characteristics: the locations of miRNA binding sites in the 3'UTR, 5'UTR, and CDS; the free energy interaction ∆G between miRNA and mRNA; the ΔG/ΔGm value, where ΔGm is equal to the free energy binding of miRNA with its full complementary nucleotide sequence; and the nucleotide interaction schemes between miRNAs and mRNAs. Out of 2565 miRNAs, miR-4778-3p, miR-6864-5p and miR-5197-3p were identified as the most effectively interacting with the gRNA of SARS-CoV, MERS-CoV and COVID-19, respectively. Based on the miR-4778-3p, miR-6864-5p and miR-5197-3p sequences, complete complementary miRNA (cc-miR) binding sites in the gRNA coronaviruses were created. The detected binding sites of these cc-miRs did not form intramolecular complexes in the 2D structure of the gRNA of SARS-CoV, MERS-CoV, and COVID-19 with a value of more than 85%. Therefore, the cc-miRs will bind gRNA at these sites without competition. The cc-miRs for SARS-CoV, MERS-CoV, and COVID-19 did not have target genes among the 17508 human coding genes with a ΔG/ΔGm of more than 85%, which implies the absence of side effects of these cc-miRs on the translation of human mRNAs. cc-miRs can be used as therapeutic agents by incorporating them into exosomes or other vesicles and introducing them into the blood or lung by inhalation. The introduction of cc-miR into the blood will suppress the reproduction of the virus in the blood and in all organs into which it can enter. The proposed method of inhibiting the reproduction of coronaviruses can be used for other viruses.
mirna如何保护人类免受冠状病毒COVID-19、SARS-CoV和MERS-CoV的侵害
病毒性疾病对人类健康造成重大危害,往往造成高死亡率。在过去的20年里,人类经历了SARS-CoV(严重急性呼吸综合征)、MERS-CoV(中东呼吸综合征)和COVID-19冠状病毒的感染,这些病毒从动物传播到人类,并在人与人之间传播。这些疾病造成了巨大的经济损失。为了对抗冠状病毒和其他病毒,建议使用mirna,它在翻译水平上调节蛋白质合成。MirTarget程序用于确定以下结合特征:miRNA结合位点在3'UTR、5'UTR和CDS中的位置;miRNA与mRNA之间的自由能相互作用∆G;为ΔG/ΔGm值,其中ΔGm等于miRNA与其完整互补核苷酸序列结合的自由能;以及mirna和mrna之间的核苷酸相互作用方案。在2565个miRNAs中,miR-4778-3p、miR-6864-5p和miR-5197-3p分别被确定为与SARS-CoV、MERS-CoV和COVID-19的gRNA最有效的相互作用。基于miR-4778-3p、miR-6864-5p和miR-5197-3p序列,在gRNA冠状病毒中建立了完整的互补miRNA (cc-miR)结合位点。检测到的这些cc-miRs结合位点在SARS-CoV、MERS-CoV和COVID-19 gRNA的2D结构中未形成分子内复合物,其值大于85%。因此,cc- mir将在没有竞争的情况下在这些位点结合gRNA。SARS-CoV、MERS-CoV和COVID-19的cc-miRs在17508个人类编码基因中没有靶基因,ΔG/ΔGm大于85%,这意味着这些cc-miRs对人类mrna的翻译没有副作用。cc- mir可作为治疗剂,将其纳入外泌体或其他囊泡中,并通过吸入将其引入血液或肺部。将cc-miR引入血液将抑制病毒在血液中的繁殖以及病毒可以进入的所有器官。所提出的抑制冠状病毒繁殖的方法可用于其他病毒。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信